|
|
||||||||
The FASEB Journal, Vol 11, 19-28, Copyright © 1997 by The Federation of American Societies for Experimental Biology
REVIEWS |
RP Elferink, GN Tytgat and AK Groen
Department of Gastrointestinal and Liver Diseases, Academic Medical Center, Amsterdam, The Netherlands.
The small apical (canalicular) domains of hepatocytes form a luminal meshwork of tubules between adjacent hepatocytes and are the sites of primary bile formation. Organic compounds are transported across this membrane domain against high concentration gradients. It has been recognized in recent years that the hepatocyte is harnessed with a set of canalicular ATP-dependent transport proteins, specialized in this uphill transport. Bile salts, organic anions, cations, and neutral amphipaths are all pumped into the bile via such primary active transporters. Functionally, these transporters resemble ABC transporters overexpressed in cells with the multidrug resistance phenotype. Indeed, those transporters that have been characterized at the molecular level turn out to be new, or already recognized, members of this family. Phospholipid secretion across the canalicular membrane of the mouse is also mediated by a member of this family, mdr2 P- glycoprotein. This was demonstrated by the absence of phospholipid secretion into bile of mice with a disrupted mdr2 gene and by subsequent demonstration of phospholipid translocation in cells that overexpress this protein. The recognition of mdr2 P-glycoprotein as a phospholipid flippase sheds new light on the function of P- glycoproteins and is an important step in understanding the mechanism of biliary lipid secretion.
This article has been cited by other articles:
![]() |
K. Murao, X. Yu, H. Imachi, W. M. Cao, K. Chen, K. Matsumoto, T. Nishiuchi, N. C. W. Wong, and T. Ishida Hyperglycemia suppresses hepatic scavenger receptor class B type I expression Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E78 - E87. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kim, K. Morimura, Y. Shah, Q. Yang, J. M. Ward, and F. J. Gonzalez Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice Carcinogenesis, May 1, 2007; 28(5): 940 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System. Physiol Rev, October 1, 2006; 86(4): 1179 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Cao, K. Murao, H. Imachi, X. Yu, H. Dobashi, K. Yoshida, T. Muraoka, N. Kotsuna, S. Nagao, N. C. W. Wong, et al. Insulin-Like Growth Factor-I Regulation of Hepatic Scavenger Receptor Class BI Endocrinology, December 1, 2004; 145(12): 5540 - 5547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tannert, D. Wustner, J. Bechstein, P. Muller, P. F. Devaux, and A. Herrmann Aminophospholipids Have No Access to the Luminal Side of the Biliary Canaliculus: IMPLICATIONS FOR THE SPECIFIC LIPID COMPOSITION OF THE BILE FLUID J. Biol. Chem., October 17, 2003; 278(42): 40631 - 40639. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mesotten, G. Van den Berghe, C. Liddle, S. Coulter, F. McDougall, R. C. Baxter, and P. J. D. Delhanty Growth Hormone Modulation of the Rat Hepatic Bile Transporter System in Endotoxin-Induced Cholestasis Endocrinology, September 1, 2003; 144(9): 4008 - 4017. [Abstract] [Full Text] [PDF] |
||||
![]() |
R O. Elferink Cholestasis Gut, May 1, 2003; 52(90002): ii42 - 48. [Abstract] [Full Text] |
||||
![]() |
S. Mulugeta, J. M. Gray, K. L. Notarfrancesco, L. W. Gonzales, M. Koval, S. I. Feinstein, P. L. Ballard, A. B. Fisher, and H. Shuman Identification of LBM180, a Lamellar Body Limiting Membrane Protein of Alveolar Type II Cells, as the ABC Transporter Protein ABCA3 J. Biol. Chem., June 14, 2002; 277(25): 22147 - 22155. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Annaert, R. Z. Turncliff, C. L. Booth, D. R. Thakker, and K. L. R. Brouwer P-Glycoprotein-Mediated In Vitro Biliary Excretion in Sandwich-Cultured Rat Hepatocytes Drug Metab. Dispos., October 1, 2001; 29(10): 1277 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lange and J. Gartzke Microvillar cell surface as a natural defense system against xenobiotics: a new interpretation of multidrug resistance Am J Physiol Cell Physiol, August 1, 2001; 281(2): C369 - C385. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Bloks, T. Plösch, H. van Goor, H. Roelofsen, J. Baller, R. Havinga, H. J. Verkade, A. van Tol, P. L. M. Jansen, and F. Kuipers Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase-deficient mice J. Lipid Res., January 1, 2001; 42(1): 41 - 50. [Abstract] [Full Text] |
||||
![]() |
G. M. Spitsen, S. Dueland, S. K. Krisans, C. J. Slattery, J. H. Miyake, and R. A. Davis In nonhepatic cells, cholesterol 7{alpha}-hydroxylase induces the expression of genes regulating cholesterol biosynthesis, efflux, and homeostasis J. Lipid Res., August 1, 2000; 41(8): 1347 - 1355. [Abstract] [Full Text] |
||||
![]() |
C. G. Panousis and S. H. Zuckerman Interferon-{gamma} Induces Downregulation of Tangier Disease Gene (ATP-Binding-Cassette Transporter 1) in Macrophage-Derived Foam Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1565 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wüstner, A. Herrmann, and P. Müller Head group-independent interaction of phospholipids with bile salts: a fluorescence and EPR study J. Lipid Res., March 1, 2000; 41(3): 395 - 404. [Abstract] [Full Text] |
||||
![]() |
K. Ogawa, H. Suzuki, T. Hirohashi, T. Ishikawa, P. J. Meier, K. Hirose, T. Akizawa, M. Yoshioka, and Y. Sugiyama Characterization of inducible nature of MRP3 in rat liver Am J Physiol Gastrointest Liver Physiol, March 1, 2000; 278(3): G438 - G446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Madon, B. Hagenbuch, L. Landmann, P. J. Meier, and B. Stieger Transport Function and Hepatocellular Localization of mrp6 in Rat Liver Mol. Pharmacol., March 1, 2000; 57(3): 634 - 641. [Abstract] [Full Text] |
||||
![]() |
J. Klucken, C. Buchler, E. Orso, W. E. Kaminski, M. Porsch-Ozcurumez, G. Liebisch, M. Kapinsky, W. Diederich, W. Drobnik, M. Dean, et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport PNAS, January 18, 2000; 97(2): 817 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Hofmann The Continuing Importance of Bile Acids in Liver and Intestinal Disease Arch Intern Med, December 13, 1999; 159(22): 2647 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ji, N. Wang, R. Ramakrishnan, E. Sehayek, D. Huszar, J. L. Breslow, and A. R. Tall Hepatic Scavenger Receptor BI Promotes Rapid Clearance of High Density Lipoprotein Free Cholesterol and Its Transport into Bile J. Biol. Chem., November 19, 1999; 274(47): 33398 - 33402. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. G. Frijters, C. J. Tuijn, R. Ottenhoff, B. N. Zegers, A. K. Groen, and R. P. J. O. Elferink The role of different P-glycoproteins in hepatobiliary secretion of fluorescently labeled short-chain phospholipids J. Lipid Res., November 1, 1999; 40(11): 1950 - 1958. [Abstract] [Full Text] |
||||
![]() |
E. R. M. Eckhardt, A. Moschetta, W. Renooij, S. S. Goerdayal, G. P. van Berge-Henegouwen, and K. J. van Erpecum Asymmetric distribution of phosphatidylcholine and sphingomyelin between micellar and vesicular phases: potential implications for canalicular bile formation J. Lipid Res., November 1, 1999; 40(11): 2022 - 2033. [Abstract] [Full Text] |
||||
![]() |
A. van Helvoort, A. de Brouwer, R. Ottenhoff, J. F. H. M. Brouwers, J. Wijnholds, J. H. Beijnen, A. Rijneveld, T. van der Poll, M. A. van der Valk, D. Majoor, et al. Mice without phosphatidylcholine transfer protein have no defects in the secretion of phosphatidylcholine into bile or into lung airspaces PNAS, September 28, 1999; 96(20): 11501 - 11506. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishizuka, K. Konno, T. Shiina, H. Naganuma, K. Nishimura, K. Ito, H. Suzuki, and Y. Sugiyama Species Differences in the Transport Activity for Organic Anions across the Bile Canalicular Membrane J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1324 - 1330. [Abstract] [Full Text] |
||||
![]() |
Y Sai, A. Nies, and I. Arias Bile acid secretion and direct targeting of mdr1-green fluorescent protein from Golgi to the canalicular membrane in polarized WIF-B cells J. Cell Sci., January 12, 1999; 112(24): 4535 - 4545. [Abstract] [PDF] |
||||
![]() |
M. Trauner, P. J. Meier, and J. L. Boyer Molecular Pathogenesis of Cholestasis N. Engl. J. Med., October 22, 1998; 339(17): 1217 - 1227. [Full Text] [PDF] |
||||
![]() |
Q. Zhou, P. J. Sims, and T. Wiedmer Expression of Proteins Controlling Transbilayer Movement of Plasma Membrane Phospholipids in the B Lymphocytes From a Patient With Scott Syndrome Blood, September 1, 1998; 92(5): 1707 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Geng, A. J. Schwab, T. Horie, C. A. Goresky, and K. S. Pang Hepatic Uptake of Bromosulfophthalein-Glutathione in Perfused Eisai Hyperbilirubinemic Mutant Rat Liver: A Multiple-Indicator Dilution Study J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 480 - 492. [Abstract] [Full Text] |
||||
![]() |
J. M. L. de Vree, E. Jacquemin, E. Sturm, D. Cresteil, P. J. Bosma, J. Aten, J.-F. Deleuze, M. Desrochers, M. Burdelski, O. Bernard, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis PNAS, January 6, 1998; 95(1): 282 - 287. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |